A new call trade has been made with Crispr Therapeutics on July 24th. Two Aug 2nd $55.00 call options were purchased for $0.78 before fees. Stop pricing has been instituted. The expectation is $1.00. Some reasons for the trade are below.
- Earnings coming on 7/29
- Hitting $50.00 resistance
**
This blog is used for informational purposes only. It should not be
used as a recommendation to buy or sell any security. Do your own due
diligence before trading or investing. If you would like up to the
moment communication on KDK Options trades, email at
kdkoptions@gmail.com **
No comments:
Post a Comment